0001209191-23-027852.txt : 20230508 0001209191-23-027852.hdr.sgml : 20230508 20230508070354 ACCESSION NUMBER: 0001209191-23-027852 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230505 FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nabel Gary J. CENTRAL INDEX KEY: 0001867450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33528 FILM NUMBER: 23895816 MAIL ADDRESS: STREET 1: C/O SIGA TECHNOLOGIES, INC. STREET 2: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPKO HEALTH, INC. CENTRAL INDEX KEY: 0000944809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752402409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-4181 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: Opko Health, Inc. DATE OF NAME CHANGE: 20070621 FORMER COMPANY: FORMER CONFORMED NAME: eXegenics Inc DATE OF NAME CHANGE: 20040505 FORMER COMPANY: FORMER CONFORMED NAME: EXEGENICS INC DATE OF NAME CHANGE: 20011114 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-05 0 0000944809 OPKO HEALTH, INC. OPK 0001867450 Nabel Gary J. 4400 BISCAYNE BLVD. MIAMI FL 33137 1 1 0 0 Chief Innovation Officer 0 Common Stock 2023-05-05 4 P 0 19285 1.78 A 94756 D Common Stock 2023-05-05 4 P 0 3185 1.793 A 97941 D Common Stock 2023-05-05 4 P 0 27777 1.80 A 125718 D Common Stock 2023-05-05 4 P 0 27624 1.81 A 153342 D Common Stock 2023-05-05 4 P 0 79334 1.82 A 232676 D Common Stock 2023-05-05 4 P 0 19475 1.829 A 252151 D Common Stock 2023-05-05 4 P 0 10928 1.83 A 263079 D Common Stock 2023-05-05 4 P 0 28538 1.82 A 19886052 I See Footnote Common Stock 2023-05-05 4 P 0 26407 1.85 A 19912459 I See Footnote Common Stock 2023-05-05 4 P 0 54945 1.82 A 19912459 I See Footnote Common Stock 2023-05-05 4 P 0 34338 1.838 A 114338 I See Footnote Common Stock 2023-05-05 4 P 0 54346 1.8399 A 168684 I See Footnote Common Stock 2023-05-05 4 P 0 20009 1.8472 A 188693 I See Footnote Common Stock 2023-05-05 4 P 0 54054 1.85 A 242747 I See Footnote Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Steven D. Rubin, Attorney-in-Fact 2023-05-08